Geode Capital Management LLC Has $261.59 Million Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Geode Capital Management LLC boosted its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 3.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,426,129 shares of the real estate investment trust’s stock after acquiring an additional 192,465 shares during the period. Geode Capital Management LLC owned approximately 2.38% of Omega Healthcare Investors worth $261,589,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. State Street Corp lifted its stake in Omega Healthcare Investors by 0.9% in the third quarter. State Street Corp now owns 12,339,753 shares of the real estate investment trust’s stock valued at $502,228,000 after buying an additional 114,085 shares in the last quarter. Assetmark Inc. raised its holdings in shares of Omega Healthcare Investors by 1.7% during the third quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust’s stock worth $48,492,000 after acquiring an additional 19,542 shares during the period. BNP Paribas Financial Markets lifted its position in Omega Healthcare Investors by 120.8% in the 3rd quarter. BNP Paribas Financial Markets now owns 226,338 shares of the real estate investment trust’s stock valued at $9,212,000 after acquiring an additional 123,836 shares in the last quarter. Daiwa Securities Group Inc. boosted its stake in Omega Healthcare Investors by 317.7% in the 3rd quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock worth $160,739,000 after purchasing an additional 3,003,845 shares during the period. Finally, Caxton Associates LP bought a new position in Omega Healthcare Investors during the 2nd quarter worth about $1,652,000. 65.25% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Omega Healthcare Investors

In related news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. This represents a 10.96 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at $4,025,000. This represents a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on OHI shares. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective for the company in a report on Thursday, October 31st. Royal Bank of Canada raised their price target on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research note on Monday, November 11th. Berenberg Bank began coverage on shares of Omega Healthcare Investors in a research report on Friday, October 18th. They issued a “buy” rating and a $45.00 price objective on the stock. BMO Capital Markets upgraded shares of Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 target price for the company in a report on Monday, December 9th. Finally, Truist Financial lifted their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research note on Wednesday, September 4th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $40.18.

Omega Healthcare Investors Stock Performance

Shares of Omega Healthcare Investors stock opened at $39.21 on Friday. The business has a 50-day moving average price of $40.38 and a two-hundred day moving average price of $37.92. Omega Healthcare Investors, Inc. has a 1-year low of $27.53 and a 1-year high of $44.42. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. The company has a market cap of $10.58 billion, a P/E ratio of 28.83, a PEG ratio of 1.21 and a beta of 0.98.

Omega Healthcare Investors Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were paid a $0.67 dividend. The ex-dividend date was Monday, November 4th. This represents a $2.68 annualized dividend and a dividend yield of 6.83%. Omega Healthcare Investors’s dividend payout ratio is presently 197.06%.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.